Research

rs41423247 — NR3C1 BclI

Intronic glucocorticoid receptor variant affecting cortisol sensitivity and stress response regulation

Strong Risk Factor

Details

Gene
NR3C1
Chromosome
5
Risk allele
G
Consequence
Regulatory
Inheritance
Codominant
Clinical
Risk Factor
Evidence
Strong
Chip coverage
v3 v4 v5

Population Frequency

CC
42%
CG
42%
GG
16%

Ancestry Frequencies

african
45%
latino
40%
european
37%
south_asian
35%
east_asian
30%

The Glucocorticoid Receptor's Sensitivity Switch

The NR3C1 gene encodes the glucocorticoid receptor, your body's primary sensor for cortisol—the stress hormone. When life throws challenges your way, your hypothalamic-pituitary-adrenal axis11 hypothalamic-pituitary-adrenal axis
The HPA axis is your body's central stress response system, triggering cortisol release from the adrenal glands
springs into action, releasing cortisol to help you cope. The BclI polymorphism, a C-to-G change 646 nucleotides downstream from exon 2, acts as a sensitivity dial for how strongly your cells respond to this cortisol signal.

The Mechanism

This intronic variant creates a BclI restriction site through a C-to-G substitution , altering the secondary structure of glucocorticoid receptor mRNA. Though it doesn't change the protein's amino acid sequence, the G allele is associated with increased glucocorticoid sensitivity in vitro, with GG carriers showing lower methylprednisolone IC50 values compared to those with C alleles. This enhanced sensitivity means GG carriers' cells respond more vigorously to the same amount of cortisol, amplifying the hormone's effects throughout the body.

The mechanism appears to involve both altered glucocorticoid receptor expression22 glucocorticoid receptor expression
GR expression levels determine how many cortisol binding sites are available in cells
and changes in negative feedback sensitivity.

In dexamethasone suppression tests, GG carriers required lower doses to suppress cortisol (0.47 mg for CC/CG vs 0.7 mg for GG) , demonstrating heightened receptor responsiveness.

The Evidence

The BclI variant's impact on mental health has been documented across multiple large studies.

A meta-analysis of 9 studies including 1,630 depressed patients and 3,362 controls found that homozygous G carriers had increased risk for depression (OR = 0.77, 95% CI = 0.64–0.94) in Caucasian populations. The paradox—increased glucocorticoid sensitivity leading to depression—reflects the complex role of cortisol dysregulation in mood disorders.

Memory and stress intersect dramatically with this variant33 Memory and stress intersect dramatically with this variant
The relationship between stress hormones and memory is bidirectional and time-dependent
.

In 841 healthy subjects, GG carriers showed enhanced emotional memory performance compared to CG and CC carriers , particularly for emotionally arousing material. However, this enhanced memory comes at a cost:

GG homozygotes had significantly more long-term traumatic memories from intensive care at 6 months post-cardiac surgery , and anxiety was more common as a traumatic memory in GG carriers (57% vs 35%), with higher PTSD symptom scores .

The variant's effects extend beyond mental health.

G allele carriers show higher blood pressure, insulin, and glucose levels in obese subjects , connecting glucocorticoid sensitivity to metabolic syndrome.

Lower BclI polymorphism frequency, GRβ overexpression, and altered cytokine expression underlie glucocorticoid resistance in metabolic syndrome , suggesting the variant modulates multiple aspects of stress-related physiology.

In pediatric leukemia treatment,

BclI polymorphism carriers showed greater susceptibility to glucocorticoid side effects including Cushingoid changes, dyspepsia, and depression symptoms . This clinical observation reinforces the functional significance of the variant.

Practical Implications

Your BclI genotype shapes how your body and brain respond to stress at a fundamental level. GG carriers experience amplified cortisol signaling, which translates to both advantages and vulnerabilities. The enhanced emotional memory can be adaptive—helping you learn from emotionally significant experiences—but may also make you more susceptible to intrusive traumatic memories and anxiety disorders.

For mental health, this matters.

The CC BclI haplotype combined with wild-type status at other NR3C1 sites significantly aggravates trait anxiety , particularly in the context of chronic stress like asthma. Understanding your genotype can inform discussions with mental health providers about stress management approaches and potential heightened vulnerability to stress-related conditions.

Metabolically, enhanced glucocorticoid sensitivity can promote central fat deposition, insulin resistance, and elevated blood pressure—all features of metabolic syndrome. This doesn't mean GG carriers are doomed to these outcomes, but rather that stress management and metabolic health monitoring become especially important.

The variant also influences response to glucocorticoid medications.

In children with asthma, GG homozygotes showed higher improvement in lung function (24.2% vs 7.9%) after high-dose inhaled corticosteroids , suggesting genotype-guided dosing might optimize treatment while minimizing side effects.

Interactions

The BclI polymorphism operates within a network of other NR3C1 variants. The N363S polymorphism (rs6195) also increases glucocorticoid sensitivity, while ER22/23EK (rs6189/rs6190) confers relative resistance.

Combined haplotype analysis shows that AA ER22/23EK, AA N363S, and CC BclI together significantly aggravate trait anxiety , demonstrating epistatic effects across the gene.

The variant also interacts with FKBP544 FKBP5
FKBP5 encodes a cochaperone protein that modulates glucocorticoid receptor sensitivity
, another key regulator of HPA axis function. While direct BclI-FKBP5 interaction studies are limited, both genes independently affect stress reactivity and mental health vulnerability, likely through overlapping pathways.

Epigenetic factors also matter.

Hypermethylation of the NR3C1 exon 1F promoter is associated with early-life adversity and increased risk for depression and anxiety . Environmental stressors can thus modify how your genetic variant expresses itself, creating gene-environment interactions that shape mental health trajectories.

For those carrying risk alleles, compound effects with early-life stress, chronic psychological stressors, or concurrent psychiatric medication use warrant consideration. The heightened glucocorticoid sensitivity means that interventions targeting stress reduction—whether through mindfulness, therapy, or lifestyle modification—may yield particularly meaningful benefits.

Genotype Interpretations

What each possible genotype means for this variant:

CC “Standard Sensitivity” Normal

Normal glucocorticoid receptor sensitivity

You have two copies of the common C allele, conferring standard glucocorticoid receptor sensitivity. Your HPA axis responds to stress with typical cortisol dynamics and your cells show normal responsiveness to cortisol signaling. About 42% of people of European descent share this genotype, making it the most common configuration alongside heterozygotes.

This genotype provides balanced stress hormone regulation without the heightened sensitivity seen in G carriers. Your cortisol feedback mechanisms operate within the normal range, and you're less likely to experience amplified stress-related symptoms or medication responses compared to G allele carriers.

CG “Moderately Increased Sensitivity” Intermediate Caution

Moderately enhanced cortisol sensitivity with intermediate stress vulnerability

The heterozygous state creates a dose-dependent effect on glucocorticoid sensitivity. Studies show that heterozygotes often cluster with CC homozygotes in analyses, but some effects—particularly emotional memory enhancement and medication response—show graded patterns.

Your intermediate sensitivity may become more apparent during periods of sustained stress or when taking glucocorticoid medications. The enhanced cortisol signaling isn't dramatic enough to consistently produce clinical effects in all carriers, but awareness of your moderately heightened sensitivity can inform health decisions.

GG “High Sensitivity” Increased Warning

Markedly enhanced cortisol sensitivity with increased stress vulnerability

The GG genotype creates the most pronounced glucocorticoid hypersensitivity across multiple body systems. In dexamethasone suppression tests, GG carriers require substantially lower doses for cortisol suppression, demonstrating enhanced negative feedback. This translates to more vigorous cellular responses to the same cortisol levels that CC or CG carriers experience.

For mental health, this means heightened risk. Meta-analyses consistently show GG homozygotes have increased depression susceptibility, more severe PTSD symptoms after trauma, and greater anxiety in chronic stress conditions. The enhanced emotional memory, while potentially adaptive in some contexts, can become maladaptive when traumatic experiences create intrusive memories.

Metabolically, the heightened sensitivity promotes the full spectrum of metabolic syndrome features during chronic stress: central obesity, insulin resistance, hypertension, and dyslipidemia. The mechanism involves cortisol's amplified effects on adipocyte differentiation, hepatic glucose production, and vascular tone.

Clinically, GG carriers show significantly enhanced responses to glucocorticoid medications—both therapeutic and adverse. This has been documented in asthma (greater bronchodilation but also greater side effect risk) and leukemia treatment (more pronounced steroid side effects).

Key References

PMID: 23148886

BclI GG carriers show increased emotional memory performance in healthy individuals

PMID: 21169818

BclI GG homozygotes have more traumatic memories and PTSD symptoms after ICU therapy

PMID: 24728165

BclI associated with altered HPA axis glucocorticoid sensitivity in Brazilians

PMID: 30213409

Meta-analysis showing BclI homozygous mutation associated with depression risk

PMID: 27507764

Lower BclI frequency and GRβ overexpression in metabolic syndrome patients

PMID: 25009637

CC BclI haplotype aggravates trait anxiety in asthma patients